In this edition of Weekly Extractions, host Adam Tubero updates us on everything that has happened recently in the world of psychedelic companies and stocks. This episode specifically features updates on $ATAI and $FTRP. Watch the video below for all of the details. Please like, share, comment, and subscribe on YouTube. There will be plenty…

Reunion Neuroscience Inc., a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares will commence trading on the Toronto Stock Exchange under the ticker symbol “REUN” at the opening of the market on August 17, 2022. Trading of the…

July was a positive month for psychedelic investors with the market showing signs of price growth.  Individual stocks such as Compass Pathways (CMPS), Relmada Therapeutics (RLMD), and Seelos Therapeutics (SEEL) were up 38.33%, 34.75%, and 29.56% respectively in the month. The overall positive performance in the psychedelic sector led to Psychedelic Invest’s Index being up…

The recent growth and excitement around the psychedelics industry have not slowed down. Not even close. In this week’s Weekly Extractions, Adam Tubero highlights several key takeaways that continue to show a prosperous future for psychedelic medicines and the respective companies involved. The entire video can be found below. In addition, don’t forget that each…